Fairvalue-Calculator Fairvalue-Calculator
EN DE

Panion & Bf Biotech Inc (1760) Fair Value & Analysis

Healthcare · TW · Market cap 5.2B TWD

Price61.40 TWD
Fair Value48.80 TWD
Upside-20.5%
Quality95/100
Evidence: High Range 31.40 TWD – 60.99 TWD

Fair value as of: Jun 24, 2026

Analysis

Panion & Bf Biotech Inc (1760) currently trades at 61.40 TWD, while our model-based Fair Value estimate is 48.80 TWD — implying the stock looks roughly 20.5% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, provides western medicines, cosmetics, testing reagents, food and chemical products in Taiwan, the United States, China, Hong Kong, Macau, and internationally. The company offers products in the areas of antibody, respiratory, gastrointestinal, COVID-19 IVD, antigen, anti-aging, active pharmaceutical ingredients, disease treatment, prevention, and veterinary products. It also offers nephrology, dermatology, pain management, hospital and household sanitization, and personal hygiene services. Panion & Bf Biotech Inc. was founded in 1976 and is headquartered in Taipei, Taiwan.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -32% Regeneron Pharmaceuticals, Inc (REGN) -4% UCB SA (UCB) -28% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) +1% Alnylam Pharmaceuticals, Inc (ALNY) -82%

Frequently asked questions

Is Panion & Bf Biotech Inc (1760) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 48.80 TWD versus a price of 61.40 TWD — about −21% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 1760?
Our 21-model fair value for Panion & Bf Biotech Inc is 48.80 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 61.40 TWD.
What is the quality score of 1760?
Panion & Bf Biotech Inc has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.